Juliet Tammenoms Bakker, 10% Owner at Inozyme Pharma, Inc. (INZY), bought 2,632,225 shares at $16.00 ($10.0M) on 2020-07-28, disclosed to the SEC on 2020-07-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,007,225 | $0 | 0.0% |
| 2 | $16.00 | 625,000 | $10.0M | 100.0% |
| Total | $3.80 avg | 2,632,225 | $10.0M | 100% |
| Filing → |
| RXST | BUY | 2024-02-15 | $407K | — | Filing → |
| RXST | SELL | 2023-11-30 | $29.4M | — | Filing → |
| RXST | SELL | 2023-11-16 | $13.6M | — | Filing → |